These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 121529

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The use of systolic time intervals in the evaluation of antihypertensive treatment with metoprolol, labetalol and prazosin.
    Buch J, Rasmussen S.
    Cor Vasa; 1983; 25(5):358-66. PubMed ID: 6653128
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Action of labetalol on heart rate, arterial pressure and systolic time intervals at rest and during exercise in hypertensive subjects].
    Cherchi A, Raffo M, Sau F, Seguro C, Pirisi R.
    Boll Soc Ital Cardiol; 1978; 23(1):158-76. PubMed ID: 754770
    [No Abstract] [Full Text] [Related]

  • 5. Clinical pharmacology of hypertension: amelioration of left ventricular performance by treatment with labetalol.
    Belogi M, Ansuini R, Pupita G, Campolucci G, Pupita F.
    Int J Clin Pharmacol Res; 1984; 4(5):385-7. PubMed ID: 6519853
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The left ventricular systolic function after digoxin administration in patients with chronic renal failure.
    Trznadel K, Luciak M, Wyszogrodzka M.
    Clin Nephrol; 1980 May; 13(5):231-4. PubMed ID: 7398145
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Serum levels of beta-methyldigoxin and contractile efficiency of the myocardium evaluated with systolic polygraphy and determination of cardiac output].
    Pelosi G, Bracchi G, Orazio S, Cereda A.
    Minerva Med; 1981 Feb 18; 72(4-5):225-31. PubMed ID: 7010220
    [Abstract] [Full Text] [Related]

  • 10. [Clinical, ergometric and polygraphic evaluation of the effects of metoprolol and labetalol administration in essential arterial hypertension. Comparative study].
    Schirripa V, Attisano N, Sarica G, Grenci G, Martelli G.
    Minerva Med; 1982 Apr 02; 73(14):845-9. PubMed ID: 7070696
    [Abstract] [Full Text] [Related]

  • 11. Significance of systolic time intervals in predicting prognosis of primary pulmonary hypertension.
    Shigematsu Y, Hamada M, Kokubu T.
    J Cardiol; 1988 Dec 02; 18(4):1109-14. PubMed ID: 3267719
    [Abstract] [Full Text] [Related]

  • 12. Sympathetic hyperreflexia in tetraplegics. The value of systolic time intervals in assessing drug effects.
    Sommers DK.
    S Afr Med J; 1980 Dec 13; 58(24):978-80. PubMed ID: 7444702
    [Abstract] [Full Text] [Related]

  • 13. Treatment of hypertension with labetalol.
    Bolli P, Waal-Manning HJ, Simpson FO, Seeman HM.
    N Z Med J; 1977 Dec 28; 86(602):557-63. PubMed ID: 306082
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of severe essential hypertension with labetalol: effect on active and inactive renin.
    Hauger-Klevene JH.
    Pharmatherapeutica; 1981 Dec 28; 3(1):46-54. PubMed ID: 7033992
    [Abstract] [Full Text] [Related]

  • 16. Hemodynamic effects of labetalol in healthy volunteers.
    Allonen H, Kanto J, Pakkanen A, Wendelin H.
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov 28; 20(11):517-9. PubMed ID: 7174154
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intravenous labetalol in severe hypertension. Effects on blood pressure, plasma renin activity and catecholamines.
    Lechi A, Picotti GB, Covi G, Pomari S, Pedrolli E, Cesura AM, Danti G, Mattioli M.
    Arzneimittelforschung; 1981 Nov 28; 31(3):524-6. PubMed ID: 7013770
    [Abstract] [Full Text] [Related]

  • 20. The hypotensive effect of a single daily dose of labetalol: a preliminary study.
    Rossi A, Ziacchi V, Lomanto B.
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep 28; 20(9):438-45. PubMed ID: 6754634
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.